Physician

Sujith R Kalmadi, MD

According to 2025 Medicare claims, Sujith Kalmadi, MD (NPI: 1508973447) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is IRONWOOD PHYSICIANS, PC (NPI: 1740269299; TIN: 731636831) and primary practice location at 85224-5665. Kalmadi is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Banner Health Network (ACO ID: A3229), Caravan Collaborative Pathways (ACO ID: A4604), Arizona Care Network (ACO ID: A5176), and Commonwealth Primary Care ACO LLC (ACO ID: D0224), participating under both the MSSP and REACH models.

Kalmadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 833 traditional Medicare patients, billed 305,505 HCPCS/CPT codes, and received $4,773,356 in Medicare payments. The top billing code was A9552 (Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries). Part D data shows 2,417 prescription claims across 331 beneficiaries totaling $4,482,461 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 60 claims. Open Payments data shows 335 records totaling $658,313. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,468,047 to $4,773,356. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,008,464 to $4,482,461. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,069 to $8,068.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	610	274,142	$2,468,047
2016	596	244,726	$2,651,733
2017	631	288,131	$2,992,069
2018	628	317,587	$3,388,953
2019	651	330,956	$4,192,563
2020	677	338,814	$5,316,899
2021	712	305,541	$4,715,783
2022	669	308,293	$4,577,218
2023	720	311,542	$4,939,759
2024	833	305,505	$4,773,356

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	2,335	$2,008,464
2016	305	2,409	$2,173,020
2017	308	2,167	$2,455,024
2018	340	2,586	$3,945,326
2019	372	2,605	$4,154,885
2020	351	2,593	$3,784,246
2021	427	2,762	$3,509,962
2022	410	2,770	$3,955,751
2023	367	2,645	$3,997,302
2024	331	2,417	$4,482,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	65	$10,340
2016	24	170	$69,455
2017	37	249	$57,444
2018	60	243	$28,330
2019	63	233	$23,772
2020	40	174	$13,442
2021	N/R	205	$17,923
2022	N/R	138	$5,849
2023	N/R	113	$19,069
2024	N/R	60	$1,667

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	163	180	$281
99442	Telephone medical discussion with physician, 11-20 minutes	158	240	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	471	1,266	$65
71260	Ct scan of chest with contrast	176	214	$47
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	194	22,325	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	21	628	$384,533
Brukinsa	Zanubrutinib	44	1,278	$369,038
Ibrance	Palbociclib	22	616	$368,954
Calquence	Acalabrutinib Maleate	24	720	$365,854
Imbruvica	Ibrutinib	21	588	$322,783

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	25	$1,097
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	23	$433
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	301	$142,571	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	32	$515,742	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$7,150	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Sujith R. Kalmadi, MD?

Tedicare shows public-source Medicare data for Sujith R. Kalmadi, MD (NPI 1508973447), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sujith R. Kalmadi, MD have ACO affiliation data?

Sujith R. Kalmadi, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Banner Health Network (MSSP, ACO ID A3229), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Arizona Care Network (MSSP, ACO ID A5176), and Commonwealth Primary Care ACO LLC (REACH, ACO ID D0224).

What billing organization is linked to Sujith R. Kalmadi, MD?

Sujith R. Kalmadi, MD is linked to IRONWOOD PHYSICIANS, PC (billing NPI 1740269299) in the available physician profile data.

Does Sujith R. Kalmadi, MD have Open Payments data?

Sujith R. Kalmadi, MD has 335 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.